GLAXO:NSE
GlaxoSmithKline Pharmaceuticals Ltd
2 508,70 ₹
arrow_downward
-0,25%(-6,40) 1D
30 հոկ, 15:30:02 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLAXO...
Open
2 527,60 ₹
High
2 528,90 ₹
Low
2 479,30 ₹
Mkt. cap
424,99 մլրդ
Avg. vol.
64,38 հզր
Volume
56,35 հզր
Dividend
2,27%
Quarterly dividend
14,25 ₹
Ex-dividend date
29 մյս, 2026 թ.
P/E ratio
39,79
52-wk high
3 120,70 ₹
52-wk low
2 088,10 ₹
EPS
63,05 ₹
Shares outstanding
169,41 մլն
No. of employees
3 հզր
Open
2 527,60 ₹
High
2 528,90 ₹
Low
2 479,30 ₹
Mkt. cap
424,99 մլրդ
Avg. vol.
64,38 հզր
Volume
56,35 հզր
Dividend
2,27%
Quarterly dividend
14,25 ₹
Ex-dividend date
29 մյս, 2026 թ.
P/E ratio
39,79
52-wk high
3 120,70 ₹
52-wk low
2 088,10 ₹
EPS
63,05 ₹
Shares outstanding
169,41 մլն
No. of employees
3 հզր
News stories
From web sources and news partners
The Motley Fool
·
22 րոպե առաջ
Is the Vanguard S&P 500 ETF Still a Buy for Long-Term Investors? Here's My Honest Take.
BigGo Finance
·
17 րոպե առաջ
Wall Street's AI Trade Cracks: Nasdaq Sheds 2.86% as Alphabet, Intel Selloffs Expose Concentration Risk
The Globe and Mail
·
47 րոպե առաջ
Should You Sell Your Stocks Right Now? Here's What a Century's Worth of History Suggests.
Yahoo Finance
·
2 ժամ առաջ
Why Is ASML Holding (NasdaqGS:ASML) Tying Executive Pay To Employee Morale?
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd